Holdings in Company / PDMR Shareholding

RNS Number : 2160T
Proteome Sciences PLC
03 January 2017
 

Proteome Sciences plc

(the "Company")

Holdings in Company and PDMR Shareholding

 

Proteome Sciences plc (AIM:PRM) received notification from Vulpes Life Science Fund ("Vulpes"), of which Martin Diggle, a non-executive director of the Company, is a director and partner, that on 28, 29 and 30 December 2016, it purchased 265,000, 250,000 and 350,000 ordinary shares of 1 pence each ("Ordinary Shares") respectively, at an average price of 5.74 pence per Ordinary Share (the "Transaction"). Following the Transaction, Vulpes (and Mr Diggle) have a beneficial interest in 53,838,125 Ordinary Shares, representing approximately 18.29% of the current issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Vulpes Life Science Fund

2.               

Reason for the Notification

a)

Position/status

Martin Diggle, non-executive director of the Company is a  director and partner of Vulpes Life Science Fund

b)

Initial notification/Amendment

Initial notification

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Proteome Sciences plc

b)

LEI

n/a

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB0003104196

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

28 December 2016

29 December 2016

30 December 2016

Price(s)

Volume(s)

5.75p

5.75p

5.725p

265,000

250,000

350,000

d)

Aggregated information:

·      Aggregated volume

·      Price

 

865,000  Ordinary Shares of 1 pence each purchased at an average price of 5.74 pence per Ordinary Share

e)

Date of the transaction

28 December 2016, 29 December 2016 and 30 December 2016

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBXGDBDXGBGRX
UK 100

Latest directors dealings